We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+9.48%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$34.5B
AUM Growth
+$1.76B
(+5.4%)
Cap. Flow
-$769M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
26.77%
Holding
1,963
New
176
Increased
1,051
Reduced
620
Closed
112
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Albemarle
ALB
|
+$68.7M |
| 2 |
GE HealthCare
GEHC
|
+$28.6M |
| 3 |
ON Semiconductor
ON
|
+$28.1M |
| 4 |
Caterpillar
CAT
|
+$22.6M |
| 5 |
IBM
IBM
|
+$20.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$94.9M |
| 2 |
Apple
AAPL
|
+$91M |
| 3 |
West Pharmaceutical
WST
|
+$69M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$61.8M |
| 5 |
Amazon
AMZN
|
+$55.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Industrials | 12.05% |
| 3 | Consumer Staples | 10.74% |
| 4 | Consumer Discretionary | 10.51% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KRTX
926
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $525K | ﹤0.01% |
2,422
-3,791
| -61% | -$812K |
|
927
LivaNova
LIVN
$4.3B
| $525K | ﹤0.01% |
10,199
+696
| +7% | +$32.7K |
|
928
Amphastar Pharmaceuticals
AMPH
$825M
| $520K | ﹤0.01% |
9,048
+161
| +2% | +$7.14K |
|
929
Zurn Elkay Water Solutions
ZWS
$8.07B
| $518K | ﹤0.01% |
19,260
+4,640
| +32% | +$106K |
|
930
O-I Glass
OI
$1.39B
| $518K | ﹤0.01% |
24,274
+1,951
| +9% | +$42.1K |
|
931
Installed Building Products
IBP
$6.13B
| $518K | ﹤0.01% |
3,694
+252
| +7% | +$29.7K |
|
|
SEM
932
DELISTED
Select Medical
SEM
| $518K | ﹤0.01% |
30,154
+2,134
| +8% | +$33.1K |
|
933
Kulicke & Soffa
KLIC
$5.3B
| $517K | ﹤0.01% |
8,700
+594
| +7% | +$30.6K |
|
934
Unum
UNM
$13.8B
| $516K | ﹤0.01% |
10,821
-304
| -3% | -$13.3K |
|
935
KBR
KBR
$4.68B
| $516K | ﹤0.01% |
7,929
-233
| -3% | -$13.9K |
|
936
Extreme Networks
EXTR
$3.86B
| $516K | ﹤0.01% |
19,789
+1,408
| +8% | +$27.8K |
|
937
Valmont Industries
VMI
$9.44B
| $515K | ﹤0.01% |
1,770
-111
| -6% | -$32.1K |
|
938
Sabra Healthcare REIT
SBRA
$5.64B
| $514K | ﹤0.01% |
43,636
+2,723
| +7% | +$31K |
|
939
Emcor
EME
$33.1B
| $513K | ﹤0.01% |
2,778
-5,617
| -67% | -$940K |
|
940
Itron
ITRI
$3.73B
| $513K | ﹤0.01% |
7,115
+571
| +9% | +$36.1K |
|
|
RADI
941
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
| $512K | ﹤0.01% |
34,369
+2,014
| +6% | +$29.7K |
|
|
AGNT
942
AGNT Inc
AGNT
$665M
| $511K | ﹤0.01% |
25,196
-1,046
| -4% | -$15.6K |
|
943
Dycom Industries
DY
$12.9B
| $511K | ﹤0.01% |
4,496
+292
| +7% | +$28.9K |
|
|
TPH
944
DELISTED
Tri Pointe Homes
TPH
| $510K | ﹤0.01% |
15,525
+896
| +6% | +$26.2K |
|
945
Axsome Therapeutics
AXSM
$12.4B
| $510K | ﹤0.01% |
7,098
+309
| +5% | +$22.8K |
|
946
Tetra Tech
TTEK
$8.23B
| $509K | ﹤0.01% |
15,550
-280
| -2% | -$8.24K |
|
947
CNO Financial Group
CNO
$4.97B
| $509K | ﹤0.01% |
21,503
-359,577
| -94% | -$8.01M |
|
948
Lamar Advertising Co
LAMR
$16.2B
| $507K | ﹤0.01% |
5,112
-79
| -2% | -$7.67K |
|
949
California Resources
CRC
$4.75B
| $507K | ﹤0.01% |
11,190
+2,473
| +28% | +$100K |
|
|
SAGE
950
DELISTED
Sage Therapeutics
SAGE
| $505K | ﹤0.01% |
10,743
+472
| +5% | +$23.5K |
|
Similar funds
ProShare Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, ProShare Advisors held 1,963 positions worth $34.5B, up 5.4% from $32.7B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
ProShare Advisors's Q2 2023 filing shows 176 new, 1,051 increased, 620 reduced and 112 closed positions. Its largest new stake was Artesian Resources: 162,581 shares worth $7.68M. The largest sale was Microsoft, an estimated $94.9M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Staples.
- ProShare Advisors's largest Q2 2023 buy was Artesian Resources: 162,581 shares worth $7.68M.
- ProShare Advisors added most to Albemarle in Q2 2023, an estimated $68.7M increase.
- ProShare Advisors's biggest Q2 2023 reduction was Microsoft, cutting an estimated $94.9M.
- ProShare Advisors fully exited Rivian in Q2 2023, selling an estimated $11.9M.
- ProShare Advisors's ten largest holdings make up 27% of its $34.5B portfolio in Q2 2023.
- ProShare Advisors opened 176 new positions and closed 112 in Q2 2023.
- ProShare Advisors's portfolio value rose 5.4% quarter-over-quarter to $34.5B.
Based on ProShare Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.